Urgent

Post-infectious glomerulonephritis (incl. post-streptococcal GN; acute nephritic syndrome)

Glomerular disease · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Immune-complex nephritis occurring after infection — classically ~1-3 weeks after group A streptococcal pharyngitis or ~3-6 weeks after streptococcal skin infection (impetigo), but increasingly staphylococcal and in older/diabetic adults. Presents as acute nephritic syndrome: haematuria (often visible, 'cola/tea-coloured' urine), proteinuria, hypertension, oedema and variable AKI, with LOW C3 that normalises within ~6-8 weeks. Treatment is largely supportive; most children recover fully, while adults (especially diabetic/elderly, staphylococcal) have a worse prognosis.

Red flags

  • Rapidly rising creatinine / crescents on biopsy — RPGN transformation needing immunosuppression
  • Hypertensive emergency (encephalopathy, pulmonary oedema) — common driver of acute deterioration
  • Persistently low C3 beyond 8 weeks or nephrotic-range proteinuria — reconsider MPGN/C3 glomerulopathy/lupus
  • Fever/new murmur/IVDU — infective endocarditis-associated GN
  • No spontaneous improvement in an adult — biopsy to exclude alternative diagnosis

Assessment

Differential diagnosis

  • IgA nephropathy (synpharyngitic haematuria, normal C3)
  • Membranoproliferative GN / C3 glomerulopathy (persistently low C3)
  • Lupus nephritis (low C3 AND C4, positive serology)
  • ANCA vasculitis / anti-GBM / other RPGN causes
  • Infective endocarditis-associated GN, shunt nephritis
  • Haemolytic uraemic syndrome (thrombocytopenia, haemolysis)

Investigations

  • Urine microscopy: dysmorphic RBCs and red cell casts (hallmark of nephritic sediment); urine PCR/ACR
  • U&E/creatinine/eGFR, BP monitoring, weight/fluid status
  • Complement C3 (low) and C4 (usually normal) — recheck at 6-8 weeks to confirm normalisation
  • Evidence of streptococcal infection: ASOT, anti-DNase B; throat/skin swabs and cultures; blood cultures if septic/endocarditis suspected
  • ANA/dsDNA, ANCA, anti-GBM, cryoglobulins and hepatitis serology to exclude alternatives
  • Renal ultrasound; renal biopsy if atypical (no preceding infection, persistent low C3 >8 weeks, nephrotic-range proteinuria, rapidly rising creatinine/RPGN, no spontaneous improvement)

Management

  • Confirm nephritic picture (haematuria + RBC casts + hypertension +/- AKI) and document low C3
  • Treat the underlying/residual infection with appropriate antibiotics if still active (does not alter established GN course but reduces ongoing antigen load and transmission)
  • Supportive management of volume overload and hypertension: sodium and fluid restriction + loop diuretic; add antihypertensives as needed
  • Manage AKI and its complications (hyperkalaemia, acidosis, overload) supportively; RRT only for standard AKI indications
  • Avoid immunosuppression in typical post-infectious GN — it is self-limiting; reserve steroids +/- cyclophosphamide for biopsy-proven crescentic/RPGN course
  • Monitor clinical recovery: diuresis and BP usually improve within 1-2 weeks; C3 normalises by ~6-8 weeks and haematuria/proteinuria may persist for months
  • Arrange nephrology follow-up; re-evaluate/biopsy if C3 stays low beyond 8 weeks or renal function fails to recover (suggests an alternative diagnosis)

Drugs & doses

Penicillin V 500 mg PO four times daily for 10 days (or amoxicillin) for residual streptococcal infection; a macrolide (e.g. clarithromycin) if penicillin-allergic [verify local dose]
Furosemide 40-80 mg PO/IV once-twice daily for volume overload/hypertension [verify local dose]
Antihypertensive for persistent hypertension: calcium-channel blocker (amlodipine 5-10 mg PO once daily); use ACEi/ARB cautiously during active AKI/hyperkalaemia [verify local dose]
Hyperkalaemia and acidosis managed with standard AKI measures as required [verify local dose]
Immunosuppression (IV methylprednisolone +/- cyclophosphamide) ONLY for biopsy-proven crescentic/RPGN transformation [verify local dose]

Disposition

Admit for significant AKI, hypertensive emergency, pulmonary oedema or atypical/severe presentation. Mild typical cases (especially children) can be managed with close outpatient nephrology follow-up, BP/urine monitoring and repeat C3 at 6-8 weeks.

Complications & pitfalls

  • Hypertension and hypertensive encephalopathy; volume overload/pulmonary oedema
  • Acute kidney injury (occasionally dialysis-requiring, more often in adults)
  • Rarely rapidly progressive (crescentic) GN
  • Persistent microscopic haematuria/proteinuria; chronic kidney disease (higher risk in adults, diabetics, staphylococcal cases)

Exam pearls

  • The triad that clinches it: nephritic sediment + LOW C3 that NORMALISES by 6-8 weeks + evidence of preceding streptococcal infection. A C3 still low after 8 weeks is a red flag for MPGN/C3 glomerulopathy or lupus — biopsy.
  • Latency distinguishes it from IgA nephropathy: post-strep GN follows infection by 1-3 weeks (pharyngitis) or 3-6 weeks (skin); IgAN haematuria is synpharyngitic.
  • Children recover almost completely; adults (especially diabetic/elderly and staphylococcus-associated infection-related GN) frequently progress — follow up and have a lower threshold to biopsy.
  • Antibiotics treat the infection, not the established glomerulonephritis — management is supportive, centred on BP and volume control.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.